Barely Significant
← all excerpts

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells.

Mol Oncol · 2026 · PMC13060644 · PMID 41194587

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.